Online citations, reference lists, and bibliographies.
← Back to Search

SPIONs As Nano-Theranostics Agents

A. Zarepour, A. Zarrabi, Arezoo Khosravi
Published 2017 · Computer Science

Cite This
Download PDF
Analyze on Scholarcy
Share
With a rapid growth in different fields of science and technology, hopes for further improvement of human life were developed; among them is progress in medicine, which is directly linked with human health. A lot of researches have been conducted specifically for improving the current modalities of diagnosis and treatment of various diseases, especially cancer. Among them is the application of nanotechnology in the field of medicine, which is known as nanomedicine that can develop new therapeutic and diagnostic concepts in all areas of medicine. Nano-theranostics, which is based on the fusion of therapeutic and diagnostic technologies by using nanoparticles, is one of the newest approaches in this field and finally leads to individualized medicine. Magnetic nanoparticle with properties such as good biocompatibility and the ability of surface engineering could be considered as a candidate for theranostic application; briefly it not only could act as a carrier for drugs in drug delivery systems but also could act as therapeutic agent in hyperthermia. Moreover, it could be used as a contrast agent in magnetic resonance imaging (MRI) or could carry imaging agent on its surface. The ability of surface modification makes it possible to transmit engineered nanoparticles to the target organs and reduce side effects of drugs on the other organs; although in this situation external magnetic field could be used for targeting either. These features made us to study the ability of magnetic nanoparticle as a nanotheranostic agent in detail. In summary, in this context we try to introduce magnetic nanoparticle, different approaches that are be used for its synthesis, its applications in the field of treatment and diagnostic and finally its usage as a nanotheranostic agent.
This paper references
10.1016/j.addr.2010.08.004
Imaging and drug delivery using theranostic nanoparticles.
S. M. Janib (2010)
10.1016/j.ijpharm.2013.01.055
Gene delivery into human cancer cells by cationic lipid-mediated magnetofection.
S. Govindarajan (2013)
10.1021/CM802978Z
Oleylamine as Both Reducing Agent and Stabilizer in a Facile Synthesis of Magnetite Nanoparticles
Z. Xu (2009)
10.1039/c1cc10582e
Pin-point chemical modification of RNA with diverse molecules through the functionality transfer reaction and the copper-catalyzed azide-alkyne cycloaddition reaction.
Kazumitsu Onizuka (2011)
10.1002/adma.201200653
Hybrid nanoparticles for detection and treatment of cancer.
M. Sailor (2012)
10.1038/nrd4477
Managing diabetes with nanomedicine: challenges and opportunities
O. Veiseh (2015)
10.1016/j.atherosclerosis.2013.03.019
Monitoring plaque inflammation in atherosclerotic rabbits with an iron oxide (P904) and (18)F-FDG using a combined PET/MR scanner.
A. Millon (2013)
10.1088/0957-4484/24/12/125102
Thermostable trypsin conjugates immobilized to biogenic magnetite show a high operational stability and remarkable reusability for protein digestion.
M. Pecova (2013)
10.1016/J.MOLLIQ.2016.06.006
A facile green synthesis of spherical Fe3O4 magnetic nanoparticles and their effect on degradation of methylene blue in aqueous solution
Prasad Cheera (2016)
10.1021/LA700883Y
Methylene blue-containing silica-coated magnetic particles: a potential magnetic carrier for photodynamic therapy.
D. B. Tada (2007)
10.1007/978-1-60761-609-2_3
Enhanced permeability and retention (EPR) effect for anticancer nanomedicine drug targeting.
K. Greish (2010)
10.1007/978-0-387-85600-1_20
APPLICATIONS OF MAGNETIC NANOPARTICLES IN BIOMEDICINE
C. Bárcena (2003)
10.1016/j.addr.2010.07.009
Nanoparticle-based theranostic agents.
J. Xie (2010)
10.1016/j.biomaterials.2011.11.069
Multifunctional nanoparticles for upconversion luminescence/MR multimodal imaging and magnetically targeted photothermal therapy.
Liang Cheng (2012)
10.1021/nl3047305
Synthetic ligand-coated magnetic nanoparticles for microfluidic bacterial separation from blood.
J. Lee (2014)
10.1021/NL062553Z
One-step, nanoparticle-mediated bacterial detection with magnetic relaxation.
C. Kaittanis (2007)
10.7150/thno.4381
Lipid- and Polymer-Based Nanostructures for Cancer Theranostics
Brian T. Luk (2012)
10.1007/s12272-013-0303-3
Application of magnetic nanoparticle for controlled tissue assembly and tissue engineering
Eunji Lee (2014)
10.1016/j.biomaterials.2010.01.010
PET/NIRF/MRI triple functional iron oxide nanoparticles.
J. Xie (2010)
10.1007/BF03245856
Magnetic nanoparticles: Synthesis, stabilization, functionalization, characterization, and applications
M. Faraji (2010)
10.1016/J.ADDR.2006.09.013
Recent advances in iron oxide nanocrystal technology for medical imaging.
C. Corot (2006)
10.1021/bc900332r
Single-domain antibody-nanoparticles: promising architectures for increased staphylococcus aureus detection specificity and sensitivity.
S. Ryan (2009)
10.1038/nnano.2010.23
Three-dimensional tissue culture based on magnetic cell levitation.
G. Souza (2010)
10.1021/acs.chemrev.5b00112
Iron Oxide Based Nanoparticles for Multimodal Imaging and Magnetoresponsive Therapy.
N. Lee (2015)
10.1517/17425240802662795
Magnetic targeting for site-specific drug delivery: applications and clinical potential
B. Polyak (2009)
10.1158/0008-5472.CAN-09-1083
Enhanced leukemia cell detection using a novel magnetic needle and nanoparticles.
Jason E. Jaetao (2009)
10.1016/j.colsurfb.2009.10.042
Amphiphilic comblike polymers enhance the colloidal stability of Fe(3)O(4) nanoparticles.
Myeongjin Kim (2010)
10.1186/1477-044X-2-7
Magnetic techniques for the isolation and purification of proteins and peptides
I. Safarik (2004)
10.1016/j.biotechadv.2013.10.013
Nanotechnology-based intelligent drug design for cancer metastasis treatment.
Yu Gao (2014)
10.2337/db10-1400
Combined Small Interfering RNA Therapy and In Vivo Magnetic Resonance Imaging in Islet Transplantation
Ping Wang (2011)
10.1016/j.biomaterials.2010.11.028
Multi-functional magnetic nanoparticles for magnetic resonance imaging and cancer therapy.
Murali M Yallapu (2011)
10.1227/01.NEU.0000175731.25414.4c
Imaging, Distribution, and Toxicity of Superparamagnetic Iron Oxide Magnetic Resonance Nanoparticles in the Rat Brain and Intracerebral Tumor
L. Muldoon (2005)
10.1016/J.BIOMATERIALS.2007.08.050
Iron oxide nanoparticles as a drug delivery vehicle for MRI monitored magnetic targeting of brain tumors.
B. Chertok (2008)
10.1039/C6RA06862F
Nanoparticles in sonodynamic therapy: state of the art review
Hongyan Xu (2016)
10.1093/brain/awn009
Pluriformity of inflammation in multiple sclerosis shown by ultra-small iron oxide particle enhancement.
Machteld M. Vellinga (2008)
10.1016/S0959-8049(01)00193-9
A future for hyperthermia in cancer treatment?
O. Nielsen (2001)
10.1021/am5036225
Current Advances in Polymer-Based Nanotheranostics for Cancer Treatment and Diagnosis
Brian T. Luk (2014)
10.1161/ATVBAHA.111.231100
Enhanced Angiogenesis by Transplantation of Mesenchymal Stem Cell Sheet Created by a Novel Magnetic Tissue Engineering Method
M. Ishii (2011)
10.1016/j.ijpharm.2015.12.051
Design, preparation, and in vitro characterization of a trimodally-targeted nanomagnetic onco-theranostic system for cancer diagnosis and therapy.
A. Zarrin (2016)
10.1089/1076327041348301
Tissue engineering using magnetite nanoparticles and magnetic force: heterotypic layers of cocultured hepatocytes and endothelial cells.
A. Ito (2004)
10.2967/jnumed.109.061846
The Advantages of Nanoparticles for PET
M. Welch (2009)
10.1186/1556-276X-9-538
Potential applications of magnetic particles to detect and treat Alzheimer's disease
M. Busquets (2014)
10.1016/j.addr.2009.11.002
Design and fabrication of magnetic nanoparticles for targeted drug delivery and imaging.
O. Veiseh (2010)
10.1016/J.JCIS.2005.02.076
Nanoengineering of iron oxide and iron oxide/silica hollow spheres by sequential layering combined with a sol-gel process.
Z. Dai (2005)
10.1021/am302883m
Facile hydrothermal synthesis and surface functionalization of polyethyleneimine-coated iron oxide nanoparticles for biomedical applications.
Hongdong Cai (2013)
10.1039/c5nr07849k
Porphyrin-loaded nanoparticles for cancer theranostics.
Y. Zhou (2016)
10.1039/c1nr11277e
Theranostic nanoplatforms for simultaneous cancer imaging and therapy: current approaches and future perspectives.
Ki Young Choi (2012)
10.1039/C5RA16776K
A multifunctional hierarchically assembled magnetic nanostructure towards cancer nano- theranostics
H. Mousavi (2015)
10.2174/092986709787458470
Functional and molecular ultrasound imaging: concepts and contrast agents.
F. Kiessling (2009)
10.1073/pnas.0805135105
Nanoparticle size and surface properties determine the protein corona with possible implications for biological impacts
M. Lundqvist (2008)
10.1016/j.biortech.2012.01.184
Enhanced phenol degradation in coking wastewater by immobilized laccase on magnetic mesoporous silica nanoparticles in a magnetically stabilized fluidized bed.
Feng Wang (2012)
10.1016/S1040-8428(01)00179-2
The cellular and molecular basis of hyperthermia.
B. Hildebrandt (2002)
10.1021/JA026501X
Size-controlled synthesis of magnetite nanoparticles.
S. Sun (2002)
10.1002/mrm.10406
MR molecular imaging of the Her‐2/neu receptor in breast cancer cells using targeted iron oxide nanoparticles
D. Artemov (2003)
10.1002/pmic.200800335
Preparation of C60‐functionalized magnetic silica microspheres for the enrichment of low‐concentration peptides and proteins for MALDI‐TOF MS analysis
H. Chen (2009)
10.1038/nnano.2007.339
Injectable nanocarriers for biodetoxification.
J. Leroux (2007)
10.1016/J.JCIS.2006.10.023
Facile synthesis of superparamagnetic magnetite nanoparticles in liquid polyols.
Wei Cai (2007)
10.1021/nn900002m
Impact of nanotechnology on drug delivery.
O. Farokhzad (2009)
10.1021/ja903300f
Porous hollow Fe(3)O(4) nanoparticles for targeted delivery and controlled release of cisplatin.
K. Cheng (2009)
10.1038/nature03968
A general strategy for nanocrystal synthesis
X. Wang (2005)
10.1039/b908397a
Magnetic resonance imaging of chemistry.
M. Britton (2010)
10.1182/BLOOD-2004-02-0655
Efficient magnetic cell labeling with protamine sulfate complexed to ferumoxides for cellular MRI.
A. Arbab (2004)
10.1039/c3cc41984c
A multifunctional nanoprobe based on Au-Fe3O4 nanoparticles for multimodal and ultrasensitive detection of cancer cells.
J. Liu (2013)
10.1021/bc200151q
Theranostics: combining imaging and therapy.
Sneha S. Kelkar (2011)
10.1039/B514130C
Biofunctional magnetic nanoparticles for protein separation and pathogen detection.
Hongwei Gu (2006)
10.1002/jbm.a.35384
Effects of physicochemical properties of nanomaterials on their toxicity.
X. Li (2015)
10.1016/j.jconrel.2011.01.024
Doxorubicin loaded iron oxide nanoparticles overcome multidrug resistance in cancer in vitro.
Forrest M Kievit (2011)
10.1016/J.BIOMATERIALS.2004.05.022
Cytotoxicity suppression and cellular uptake enhancement of surface modified magnetic nanoparticles.
A. Gupta (2005)
10.1016/j.biomaterials.2015.09.018
Nanoscale theranostics for physical stimulus-responsive cancer therapies.
Q. Chen (2015)
10.1016/S0168-1605(99)00196-8
The use of immuno-magnetic separation (IMS) as a tool in a sample preparation method for direct detection of L. monocytogenes in cheese.
M. Uyttendaele (2000)
10.1007/s11671-008-9174-9
Magnetic Iron Oxide Nanoparticles: Synthesis and Surface Functionalization Strategies
W. Wu (2008)
10.1016/S0304-8853(00)01254-3
Optimization of ferrofluids and protocols for the enrichment of breast tumor cells in blood
P. Liberti (2001)
10.1021/ar200084x
Dextran-coated iron oxide nanoparticles: a versatile platform for targeted molecular imaging, molecular diagnostics, and therapy.
C. Tassa (2011)
10.1007/s00330-002-1721-7
Ferucarbotran (Resovist): a new clinically approved RES-specific contrast agent for contrast-enhanced MRI of the liver: properties, clinical development, and applications
P. Reimer (2002)
10.1016/j.biomaterials.2013.01.086
Near-infrared laser light mediated cancer therapy by photothermal effect of Fe3O4 magnetic nanoparticles.
Maoquan Chu (2013)
10.1016/j.biomaterials.2011.08.053
Polymer encapsulated upconversion nanoparticle/iron oxide nanocomposites for multimodal imaging and magnetic targeted drug delivery.
Haipeng Xu (2011)
10.1088/0957-4484/17/11/010
Structural and magnetic properties of uniform magnetite nanoparticles prepared by high temperature decomposition of organic precursors
A. G. Roca (2006)
10.1088/0022-3727/42/22/224003
Progress in functionalization of magnetic nanoparticles for applications in biomedicine
C. Berry (2009)
10.1002/0470093978
Physical Principles of Medical Ultrasonics: Hill/Physical Principles of Medical Ultrasonics, Second Edition
C. R. Hill (2005)
10.1038/nrd2290
Molecular imaging in drug development
J. Willmann (2008)
10.1021/nn101643u
Effects of nanoparticle size on cellular uptake and liver MRI with polyvinylpyrrolidone-coated iron oxide nanoparticles.
J. Huang (2010)
10.1039/c2cc16891j
Preparation of graphene-encapsulated magnetic microspheres for protein/peptide enrichment and MALDI-TOF MS analysis.
Q. Liu (2012)
10.1016/J.PROGSOLIDSTCHEM.2005.11.010
Magnetic nanoparticle design for medical applications
S. Mornet (2006)
10.1016/j.jcis.2009.04.046
Cell toxicity of superparamagnetic iron oxide nanoparticles.
M. Mahmoudi (2009)
10.1002/smll.200901158
Effect of surface properties on nanoparticle-cell interactions.
Ayush Verma (2010)
10.1053/CRAD.2003.1157
Magnetic resonance imaging of short T2 components in tissue.
P. Gatehouse (2003)
10.1002/adma.201306192
Integrating oxaliplatin with highly luminescent carbon dots: an unprecedented theranostic agent for personalized medicine.
Min Zheng (2014)
10.1016/j.biomaterials.2011.01.021
The effect of surface charge on in vivo biodistribution of PEG-oligocholic acid based micellar nanoparticles.
K. Xiao (2011)
10.1073/PNAS.0601755103
Targeted nanoparticle-aptamer bioconjugates for cancer chemotherapy in vivo.
O. Farokhzad (2006)
10.1016/S1369-7021(11)70163-8
Magnetite Nanoparticles for Medical MR Imaging.
Zachary Stephen (2011)
10.1088/2053-1591/2/12/125002
Synthesis, characterization and application of polyglycerol coated Fe3O4 nanoparticles as a nano-theranostics agent
Marzieh Jahandar (2015)
10.1016/j.colsurfb.2009.08.044
A new approach for the in vitro identification of the cytotoxicity of superparamagnetic iron oxide nanoparticles.
M. Mahmoudi (2010)
10.1039/C4RA16454G
Polymer/gold hybrid nanoparticles: from synthesis to cancer theranostic applications
X. Wu (2015)
10.7150/thno.15335
Targeted Nanotheranostics for Future Personalized Medicine: Recent Progress in Cancer Therapy
Sung Duk Jo (2016)
10.1088/0022-3727/36/13/201
TOPICAL REVIEW: Applications of magnetic nanoparticles in biomedicine
Q. Pankhurst (2003)
10.1155/2013/428027
The History of Hyperthermia Rise and Decline
Sergey V Roussakow (2013)
10.1016/j.jpba.2014.04.017
Magnetic separation techniques in sample preparation for biological analysis: a review.
Jincan He (2014)
10.1002/JBM.A.30909
Synthesis and characterization of biocompatible Fe3O4 nanoparticles.
J. Sun (2007)
10.1158/1078-0432.CCR-06-0946
Vascular Targeted Nanoparticles for Imaging and Treatment of Brain Tumors
G. R. Reddy (2006)
10.1016/j.phrs.2010.01.014
Magnetic nanoparticles and targeted drug delivering.
J. Chomoucka (2010)
10.1038/srep07072
Multifunctional Core/Shell Nanoparticles Cross-linked Polyetherimide-folic Acid as Efficient Notch-1 siRNA Carrier for Targeted Killing of Breast Cancer
H. Yang (2014)
10.1002/CHIN.200837219
Synthesis, Properties and Biomedical Applications of Magnetic Nanoparticles.
P. Tartaj (2008)
10.1002/smll.201200575
Superparamagnetic iron oxide nanoparticles (SPION) for the treatment of antibiotic-resistant biofilms.
Erik N. Taylor (2012)
10.17219/acem/60879
The Nanopharmacology and Nanotoxicology of Nanomaterials: New Opportunities and Challenges.
A. Radomska (2016)
10.1016/S1567-2719(05)16005-3
chapter 5 Synthesis, Properties and Biomedical Applications of Magnetic Nanoparticles
P. Tartaj (2006)
10.1016/j.biomaterials.2014.10.064
Magnetic nanoparticle clusters for photothermal therapy with near-infrared irradiation.
S. Shen (2015)
10.1088/0957-4484/21/10/105105
Gold hybrid nanoparticles for targeted phototherapy and cancer imaging.
D. Kirui (2010)
10.1021/ar700183b
Controlling transport and chemical functionality of magnetic nanoparticles.
Andrew H. Latham (2008)
10.3390/ijms11041759
Paramagnetic Liposome Nanoparticles for Cellular and Tumour Imaging
N. Kamaly (2010)
10.1021/am501067j
Thermoresponsive Magnetic Hydrogels as Theranostic Nanoconstructs
M. Jaiswal (2014)
10.1002/wnan.1219
Current status and prospects for microbubbles in ultrasound theranostics.
K. H. Martin (2013)
10.1186/1745-6673-2-16
Nanotechnology-based drug delivery systems
S. Suri (2007)
10.2147/IJN.S83150
Ultrasmall cationic superparamagnetic iron oxide nanoparticles as nontoxic and efficient MRI contrast agent and magnetic-targeting tool
Mayara K Uchiyama (2015)
10.1016/S1359-0286(02)00117-1
Biodegradable nanoparticles for drug delivery and targeting
M. Hans (2002)
10.1006/CYTO.1999.0568
Effects of hyperthermia and tumour necrosis factor on inflammatory cytokine secretion and procoagulant activity in endothelial cells.
M. Gnant (2000)
10.1016/j.jconrel.2010.08.027
To exploit the tumor microenvironment: Passive and active tumor targeting of nanocarriers for anti-cancer drug delivery.
F. Danhier (2010)
10.1002/mrm.10585
Imaging the fate of implanted bone marrow stromal cells labeled with superparamagnetic nanoparticles
P. Jendelová (2003)
10.1186/1471-2121-7-30
Optimization of immunomagnetic separation for cord blood-derived hematopoietic stem cells
T. Kekarainen (2005)
10.1586/erm.13.15
Nanotheranostics for personalized medicine
T. Kim (2013)
10.2147/IJN.S36654
Targeted therapy using nanotechnology: focus on cancer
V. Sanna (2014)
10.1016/j.coph.2014.08.002
Superparamagnetic iron oxide nanoparticles for MR imaging and therapy: design considerations and clinical applications.
Rongrong Jin (2014)
10.1039/C3TB20452A
Multifunctional Chitosan Magnetic-Graphene (CMG) Nanoparticles: a Theranostic Platform for Tumor-targeted Co-delivery of Drugs, Genes and MRI Contrast Agents.
C. Wang (2013)
10.1039/c4nr07682f
Nanocarriers in therapy of infectious and inflammatory diseases.
Ufuoma Ikoba (2015)
10.1016/j.tibtech.2015.06.006
Harnessing magnetic-mechano actuation in regenerative medicine and tissue engineering.
L. Santos (2015)
10.1016/J.JMMM.2015.06.040
Synergistic effect of the combination of triethylene-glycol modified Fe3O4 nanoparticles and ultrasound wave on MCF-7 cells
Ali Ebrahimi Fard (2015)
10.1016/j.biotechadv.2013.03.005
Surface modification of iron oxide nanoparticles by biocompatible polymers for tissue imaging and targeting.
M. Muthiah (2013)
10.1155/2012/452767
Evaluation on cartilage morphology after intra-articular injection of titanium dioxide nanoparticles in rats
Jiangxue Wang (2012)
10.1088/0022-3727/40/19/001
Magnetic Properties of Variable-sized Fe3O4 Nanoparticles Synthesized from Non-aqueous Homogeneous Solutions of Polyols
D. Caruntu (2007)
10.1016/j.jpba.2011.01.010
Development of a quantitative PCR assay for residual mouse DNA and comparison of four sample purification methods for DNA isolation.
H. Cai (2011)
10.1039/c2cs15260f
The unique role of nanoparticles in nanomedicine: imaging, drug delivery and therapy.
T. Doane (2012)
10.1016/j.ejpb.2008.08.009
Current in vitro methods in nanoparticle risk assessment: limitations and challenges.
A. Kroll (2009)
10.1148/radiol.12102394
Molecular body imaging: MR imaging, CT, and US. part I. principles.
M. Kircher (2012)
10.1002/ADFM.201201060
Hyperbranched Polyglycerol‐Grafted Superparamagnetic Iron Oxide Nanoparticles: Synthesis, Characterization, Functionalization, Size Separation, Magnetic Properties, and Biological Applications
L. Zhao (2012)
10.1109/msp.2002.1012356
Principles of Magnetic Resonance Imaging: a Signal Processing Perspective [Book Review]
Zhi Liang (2002)
10.1021/LA063415S
Relaxometric and magnetic characterization of ultrasmall iron oxide nanoparticles with high magnetization. Evaluation as potential T1 magnetic resonance imaging contrast agents for molecular imaging.
E. Taboada (2007)
10.1039/B712795B
Monodisperse water-soluble magnetite nanoparticles prepared by polyol process for high-performance magnetic resonance imaging.
J. Wan (2007)
10.1016/j.biomaterials.2014.04.063
Iron/iron oxide core/shell nanoparticles for magnetic targeting MRI and near-infrared photothermal therapy.
Z. Zhou (2014)
10.1016/j.biotechadv.2015.02.003
Tailored functionalization of iron oxide nanoparticles for MRI, drug delivery, magnetic separation and immobilization of biosubstances.
K. Holá (2015)
10.1021/bc200396r
Site-specific immobilization of enzymes on magnetic nanoparticles and their use in organic synthesis.
Ching-Ching Yu (2012)
10.1016/J.JMMM.2005.01.032
Advances in magnetofection—magnetically guided nucleic acid delivery
U. Schillinger (2005)
10.1016/J.JMMM.2005.01.053
A method for synthesis and functionalization of ultrasmall superparamagnetic covalent carriers based on maghemite and dextran
S. Mornet (2005)
10.1021/cr300068p
Magnetic nanoparticles: design and characterization, toxicity and biocompatibility, pharmaceutical and biomedical applications.
L. H. Reddy (2012)
10.1016/j.drudis.2012.03.010
Theranostic applications of nanoparticles in cancer.
Naveed Ahmed (2012)
10.1002/mrm.24622
Induced clustered nanoconfinement of superparamagnetic iron oxide in biodegradable nanoparticles enhances transverse relaxivity for targeted theranostics
Ragy R. T. Ragheb (2013)
10.1016/J.CEJ.2015.02.032
Covalent attachment of xylanase on functionalized magnetic nanoparticles and determination of its activity and stability
Asieh Soozanipour (2015)
10.1021/nn403617j
In vivo tumor targeting and image-guided drug delivery with antibody-conjugated, radiolabeled mesoporous silica nanoparticles.
F. Chen (2013)
10.1016/j.bios.2008.08.020
Electrically active polyaniline coated magnetic (EAPM) nanoparticle as novel transducer in biosensor for detection of Bacillus anthracis spores in food samples.
S. Pal (2009)
10.1016/J.MATERRESBULL.2005.09.015
Synthesis and magnetic properties of Fe3O4 nanoparticles
Yuanhui Zheng (2006)
10.1016/J.COLSURFA.2011.04.032
Multifunctional poly(aspartic acid) nanoparticles containing iron oxide nanocrystals and doxorubicin for simultaneous cancer diagnosis and therapy
Hee-Man Yang (2011)
10.1021/NL049126A
Photoacoustic tomography of a nanoshell contrast agent in the in vivo rat brain
Y. Wang (2004)
10.1088/0022-3727/45/19/195001
Nanoscale size effect on surface spin canting in iron oxide nanoparticles synthesized by the microemulsion method
M. Darbandi (2012)
10.1016/j.drudis.2015.06.008
Therapeutic approaches of magnetic nanoparticles for the central nervous system.
F. Dilnawaz (2015)
10.1016/J.JMMM.2014.12.007
A quantitative study of particle size effects in the magnetorelaxometry of magnetic nanoparticles using atomic magnetometry
Vladimir Dolgovskiy (2015)
10.1021/JA001628C
Synthesis and Magnetic Studies of Uniform Iron Nanorods and Nanospheres
†. Park (2000)
10.1146/annurev-bioeng-071812-152409
Multifunctional nanoparticles for drug delivery and molecular imaging.
G. Bao (2013)
10.1002/nbm.1606
MRI of inducible P‐selectin expression in human activated platelets involved in the early stages of atherosclerosis
Marie-Josée Jacobin-Valat (2011)
10.2147/IJN.S94255
Hyperthermia treatment of tumors by mesenchymal stem cell-delivered superparamagnetic iron oxide nanoparticles
T. Kalber (2016)
10.1038/nprot.2007.352
Generation of magnetic nonviral gene transfer agents and magnetofection in vitro
O. Mykhaylyk (2007)
10.1073/PNAS.97.16.9226
Positron emission tomography provides molecular imaging of biological processes.
M. Phelps (2000)
10.1023/A:1021231527095
Synthesis and Magnetic Properties of Fe3O4 Nanoparticles
Z. L. Liu (2002)
10.1021/ar200090c
Monodisperse magnetic nanoparticles for theranostic applications.
Don N. Ho (2011)
10.1039/c1cs15248c
Designed synthesis of uniformly sized iron oxide nanoparticles for efficient magnetic resonance imaging contrast agents.
N. Lee (2012)
10.1016/j.jconrel.2013.07.029
SPIO nanoparticle-stabilized PAA-F127 thermosensitive nanobubbles with MR/US dual-modality imaging and HIFU-triggered drug release for magnetically guided in vivo tumor therapy.
Hsin-Yang Huang (2013)
10.1016/j.addr.2011.03.008
Magnetic nanomaterials for hyperthermia-based therapy and controlled drug delivery.
Challa S. S. R. Kumar (2011)
10.1186/1556-276X-9-415
La 1−xx
M. Culebras (2014)
10.1016/j.drudis.2010.08.006
Cancer nanotechnology: application of nanotechnology in cancer therapy.
R. Misra (2010)
10.1016/S1369-7021(05)00893-X
Magnetic nanoparticle probes
L. LaConte (2005)
10.1016/J.JMMM.2005.01.064
Superparamagnetic nanoparticles for biomedical applications: Possibilities and limitations of a new drug delivery system
T. Neuberger (2005)
10.1186/1477-044X-2-1
Biological effects of power frequency magnetic fields: Neurochemical and toxicological changes in developing chick embryos
P. Rajendra (2004)
10.1021/NL061412U
Multifunctional polymeric micelles as cancer-targeted, MRI-ultrasensitive drug delivery systems.
N. Nasongkla (2006)
10.1002/ANIE.200602866
Magnetic nanoparticles: synthesis, protection, functionalization, and application.
A. Lu (2007)
10.1002/adma.201103521
Facile synthesis of monodisperse superparamagnetic Fe3O4 Core@hybrid@Au shell nanocomposite for bimodal imaging and photothermal therapy.
Wen-jie Dong (2011)
10.1016/J.PCRYSGROW.2008.08.003
Synthesis, properties, and applications of magnetic iron oxide nanoparticles
A. Teja (2009)
10.1088/0022-3727/36/13/202
The preparation of magnetic nanoparticles for applications in biomedicine
P. Tartaj (2003)
10.1007/s10853-015-9324-2
Magnetic nanoparticles: material engineering and emerging applications in lithography and biomedicine
Y. Bao (2015)
10.1002/cmmi.267
Influence of molecular parameters and increasing magnetic field strength on relaxivity of gadolinium- and manganese-based T1 contrast agents.
P. Caravan (2009)
10.1155/2012/614094
Biocompatibility and toxicity of magnetic nanoparticles in regenerative medicine
H. Markides (2012)
10.1016/j.biomaterials.2011.05.019
Iron oxide nanoparticle-containing microbubble composites as contrast agents for MR and ultrasound dual-modality imaging.
Z. Liu (2011)
10.1016/J.COCHE.2015.01.003
Synthesis and processing of magnetic nanoparticles
D. Stanicki (2015)
10.1056/NEJMRA0912273
Current concepts: Nanomedicine
Betty Y. S. Kim (2010)
Development of Protein-Functionalized Magnetic Iron Oxide Nanoparticles: Potential Application in Water Treatment
C. Okoli (2012)
10.1002/DDR.20067
Magnetic nanoparticles for drug delivery
J. Dobson (2006)
10.1021/BC060195L
Highly-efficient purification of native polyhistidine-tagged proteins by multivalent NTA-modified magnetic nanoparticles.
J. S. Kim (2007)
10.7150/thno.4827
Multifunctional Iron Oxide Nanoparticles for Diagnostics, Therapy and Macromolecule Delivery
S. K. Yen (2013)
10.1088/0957-4484/26/42/425704
Thermal and magnetic properties of iron oxide colloids: influence of surfactants.
P. P. Soares (2015)
10.1021/JA076086E
Magnetic glyco-nanoparticles: a unique tool for rapid pathogen detection, decontamination, and strain differentiation.
Kheireddine El-Boubbou (2007)
10.7150/thno.5411
Superparamagnetic Iron Oxide Nanoparticles: Amplifying ROS Stress to Improve Anticancer Drug Efficacy
G. Huang (2013)
10.1186/1471-2121-7-1
Pim kinases phosphorylate multiple sites on Bad and promote 14-3-3 binding and dissociation from Bcl-XL
A. Macdonald (2005)
10.1002/cbic.200300730
Use of Magnetic Nanoparticles as Nanosensors to Probe for Molecular Interactions
J. M. Pérez (2004)
10.1002/adma.201300081
Nano-sized CT contrast agents.
N. Lee (2013)
10.1021/ar9000026
Multifunctional magnetic nanoparticles: design, synthesis, and biomedical applications.
J. Gao (2009)
10.1016/J.JMMM.2004.11.093
Synthesis of ferrofluid with magnetic nanoparticles by sonochemical method for MRI contrast agent
E. Kim (2005)
10.2217/17435889.3.5.703
Clearance properties of nano-sized particles and molecules as imaging agents: considerations and caveats.
M. Longmire (2008)
10.1016/J.JCIS.2004.10.073
Sonochemical synthesis of stable hydrosol of Fe3O4 nanoparticles.
R. Abu Mukh-Qasem (2005)
10.1016/J.JMMM.2005.02.055
Detoxification of blood using injectable magnetic nanospheres: A conceptual technology description
M. Kaminski (2005)
10.1038/nbt951
A nanoliter-scale nucleic acid processor with parallel architecture
J. Hong (2004)
10.1016/S0168-3659(99)00248-5
Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review.
H. Maeda (2000)
10.1002/adma.201104964
Multimodal imaging guided photothermal therapy using functionalized graphene nanosheets anchored with magnetic nanoparticles.
K. Yang (2012)
Uses and applications of microemulsions
B. K. Paul (2001)
10.1016/j.copbio.2013.02.020
Recent progress in nanomedicine: therapeutic, diagnostic and theranostic applications.
L. Rizzo (2013)
Synthesis of Sterile and Pyrogen Free Biogenic Magnetic Nanoparticles: Biotechnological Potential of Magnetotactic Bacteria for Production of Nanomaterials
Saeid Ghorbanzadeh-Mashkani (2013)
10.1016/j.biotechadv.2013.05.009
Magnetic separations in biotechnology.
L. Borlido (2013)
10.2214/AJR.14.12733
Iron-based superparamagnetic nanoparticle contrast agents for MRI of infection and inflammation.
A. Neuwelt (2015)
10.1016/J.ATHEROSCLEROSIS.2006.08.048
Superparamagnetic iron oxide binding and uptake as imaged by magnetic resonance is mediated by the integrin receptor Mac-1 (CD11b/CD18): implications on imaging of atherosclerotic plaques.
C. von zur Muhlen (2007)
10.15171/bi.2016.16
Infection-resistant MRI-visible scaffolds for tissue engineering applications
M. Mahmoudi (2016)
10.1016/J.BIOMATERIALS.2004.10.012
Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications.
A. Gupta (2005)
10.1016/j.tibtech.2011.03.001
Cancer theranostics: the rise of targeted magnetic nanoparticles.
Adam J. Cole (2011)
10.1016/J.CEJ.2011.04.039
Immobilization of cellulase enzyme on superparamagnetic nanoparticles and determination of its activity and stability
Kamyar Khoshnevisan (2011)
10.1016/S0142-9612(03)00237-0
Dextran and albumin derivatised iron oxide nanoparticles: influence on fibroblasts in vitro.
C. Berry (2003)
10.1038/nrd4333
Multifunctional, stimuli-sensitive nanoparticulate systems for drug delivery
V. Torchilin (2014)
10.1039/b815548h
Magnetic nanoparticles: synthesis, functionalization, and applications in bioimaging and magnetic energy storage.
N. Frey (2009)
10.3390/molecules18055954
Green Biosynthesis and Characterization of Magnetic Iron Oxide (Fe3O4) Nanoparticles Using Seaweed (Sargassum muticum) Aqueous Extract
Mahnaz Mahdavi (2013)
10.1016/j.addr.2009.03.007
Magnetic nanoparticles for theragnostics.
V. Shubayev (2009)
10.1021/am201311c
Biocompatible magnetite/gold nanohybrid contrast agents via green chemistry for MRI and CT bioimaging.
Sreeja Narayanan (2012)
10.1021/mp200006f
HSA coated iron oxide nanoparticles as drug delivery vehicles for cancer therapy.
Qimeng Quan (2011)
10.1021/nn101307r
Single-domain protein A-engineered magnetic nanoparticles: toward a universal strategy to site-specific labeling of antibodies for targeted detection of tumor cells.
S. Mazzucchelli (2010)
10.7150/thno.8698
Nanotheranostics ˗ Application and Further Development of Nanomedicine Strategies for Advanced Theranostics
M. Muthu (2014)
10.1021/NL0502569
Optical and MRI multifunctional nanoprobe for targeting gliomas.
O. Veiseh (2005)
10.1002/CPLU.201300276
"Clicking" Porphyrins to Magnetic Nanoparticles for Photodynamic Therapy.
Merlyn Thandu (2014)
10.1007/s00330-004-2405-2
Capacity of human monocytes to phagocytose approved iron oxide MR contrast agents in vitro
S. Metz (2004)
10.1016/j.biomaterials.2010.02.068
Multifunctional doxorubicin loaded superparamagnetic iron oxide nanoparticles for chemotherapy and magnetic resonance imaging in liver cancer.
Jin Hee Maeng (2010)
10.1002/adma.201302627
Enhanced efficacy of superparamagnetic iron oxide nanoparticles against antibiotic-resistant biofilms in the presence of metabolites.
N. G. Durmus (2013)
10.1263/JBB.104.288
Magnetic force-based cell patterning using Arg-Gly-Asp (RGD) peptide-conjugated magnetite cationic liposomes.
A. Ito (2007)
10.2217/nnm.14.4
Formulation design facilitates magnetic nanoparticle delivery to diseased cells and tissues.
D. Singh (2014)
10.1016/B978-0-12-416020-0.00009-7
Tissue engineering using magnetite nanoparticles.
A. Ito (2011)
10.1016/j.yexmp.2008.12.004
Nanoparticle-based targeted drug delivery.
R. Singh (2009)
10.1517/17425241003677731
Triggered drug delivery from biomaterials
C. McCoy (2010)
10.1002/anie.200701674
Chemical design of nanoparticle probes for high-performance magnetic resonance imaging.
Y. Jun (2008)
10.1155/2016/2412958
Value of Functionalized Superparamagnetic Iron Oxide Nanoparticles in the Diagnosis and Treatment of Acute Temporal Lobe Epilepsy on MRI
Tingting Fu (2016)
10.1007/978-3-662-48544-6
Advances in Nanotheranostics II
Zhifei Dai (2016)
10.1155/2012/785920
Needleless electrospinning of uniform nanofibers using spiral coil spinnerets
X. Wang (2012)
10.1142/9789814635424_0003
Magnetic Nanomaterials for Tumor Targeting Theranostics
Leyong Zeng (2016)
10.1016/S1359-6446(03)02903-9
Nanotech approaches to drug delivery and imaging.
S. Sahoo (2003)
10.1039/c2cs15337h
Biological applications of magnetic nanoparticles.
M. Colombo (2012)
10.1016/S0304-8853(00)01239-7
Presentation of a new magnetic field therapy system for the treatment of human solid tumors with magnetic fluid hyperthermia
A. Jordan (2001)
Physicochemical characterization of ultrasmall superparamagnetic iron oxide particles (USPIO) for biomedical application as MRI contrast agents
M. Di Marco (2007)
10.4178/epih/e2015020
Antimicrobial properties of nanomolecules: potential candidates as antibiotics in the era of multi-drug resistance
Venkataramana Kandi (2015)
10.1021/la200772e
Colloidal stability of magnetic iron oxide nanoparticles: influence of natural organic matter and synthetic polyelectrolytes.
S. Ghosh (2011)
10.1016/J.APCATB.2004.11.022
Synthesis and characterization of Y2O3/Fe2O3/TiO2 nanoparticles by sol–gel method
A. Ismail (2005)
10.1021/JA0651355
A biocompatible method of decorporation: bisphosphonate-modified magnetite nanoparticles to remove uranyl ions from blood.
L. Wang (2006)
10.1021/JA072210I
Thermally cross-linked superparamagnetic iron oxide nanoparticles: synthesis and application as a dual imaging probe for cancer in vivo.
Haerim Lee (2007)
10.1016/J.JMMM.2004.11.119
Magnetic nanoparticles as markers for cellular MR imaging
J. Bulte (2005)
10.1002/adma.201501942
Rational Design and Synthesis of γFe2 O3 @Au Magnetic Gold Nanoflowers for Efficient Cancer Theranostics.
Jie Huang (2015)
10.1016/j.nano.2011.05.016
Nanoparticles: a boon to drug delivery, therapeutics, diagnostics and imaging.
S. Parveen (2012)
10.1016/j.actbio.2009.09.017
A novel route in bone tissue engineering: magnetic biomimetic scaffolds.
N. Bock (2010)
10.1016/j.carbpol.2014.10.076
Theranostic magnetoliposomes coated by carboxymethyl dextran with controlled release by low-frequency alternating magnetic field.
H. Guo (2015)
10.1002/anie.200901791
Ultrasensitive detection of bacteria using core-shell nanoparticles and an NMR-filter system.
Hakho Lee (2009)
10.1007/s13346-015-0274-7
A concise review on smart polymers for controlled drug release
Arezou Aghabegi Moghanjoughi (2015)
10.2174/138955710791185073
Recent development and application of magnetic nanoparticles for cell labeling and imaging.
Chao Zhang (2010)
10.3390/ijms140714550
Chemical and Colloidal Stability of Carboxylated Core-Shell Magnetite Nanoparticles Designed for Biomedical Applications
M. Szekeres (2013)
10.1016/j.addr.2008.03.014
Multifunctional magnetic nanoparticles for targeted imaging and therapy.
J. Mccarthy (2008)
10.1109/I2MTC.2015.7151498
Chemical and magnetic properties characterization of magnetic nanoparticles
E. Bertolucci (2015)
10.1007/s12350-010-9246-y
Single photon-emission computed tomography
T. Holly (2010)
10.1039/B406727D
Stimuli responsive polymers for biomedical applications.
Carolina de las Heras Alarcón (2005)
10.1039/c1cs15135e
Rapid determination of enantiomeric excess: a focus on optical approaches.
D. Leung (2012)
10.1016/j.scr.2012.05.005
Neuroprotective effects and magnetic resonance imaging of mesenchymal stem cells labeled with SPION in a rat model of Huntington's disease.
L. Moraes (2012)
10.1186/1745-6673-2-1
Reference values and physiological characterization of a specific isolated pig kidney perfusion model
V. Unger (2007)
10.1021/AC052015R
Aptamer-conjugated nanoparticles for selective collection and detection of cancer cells.
Joshua K Herr (2006)
10.1039/C4CS00322E
Emerging translational research on magnetic nanoparticles for regenerative medicine.
Y. Gao (2015)
10.1021/LA035648E
Superparamagnetism of magnetite nanoparticles: dependence on surface modification.
M. Mikhaylova (2004)
10.2174/138527281911150610100548
Biomedical Applications of Superparamagnetic Nanoparticles in Molecular Scale
M. Rahman (2015)
10.1038/nnano.2007.387
Nanocarriers as an emerging platform for cancer therapy.
D. Peer (2007)
10.7150/thno.10069
Magnetoliposomes Loaded with Poly-Unsaturated Fatty Acids as Novel Theranostic Anti-Inflammatory Formulations
D. Calle (2015)
10.1021/mp100228v
Nanotheranostics and image-guided drug delivery: current concepts and future directions.
T. Lammers (2010)
10.1080/02656730110108785
Magnetically mediated hyperthermia: current status and future directions
P. Moroz (2002)
10.1039/A910201I
Sub-micrometer CoAl2O4 pigment particles : synthesis and preparation of coatings
J. Merikhi (2000)
10.1038/nmeth.1322
Universal sample preparation method for proteome analysis
J. Wisniewski (2009)
10.3109/13645706.2010.481398
Nanotechnologies in regenerative medicine
Š. Kubinová (2010)
10.1002/adma.201000260
Synthesis, functionalization, and biomedical applications of multifunctional magnetic nanoparticles.
R. Hao (2010)
10.1016/j.addr.2010.09.002
Development and applications of photo-triggered theranostic agents.
P. Rai (2010)
10.1021/ar200106e
Molecular imaging with theranostic nanoparticles.
J. Jokerst (2011)
10.1021/cr068445e
Magnetic iron oxide nanoparticles: synthesis, stabilization, vectorization, physicochemical characterizations, and biological applications.
S. Laurent (2008)
10.1016/j.addr.2009.11.008
Better safe than sorry: Understanding the toxicological properties of inorganic nanoparticles manufactured for biomedical applications.
B. Fadeel (2010)
10.1088/0022-3727/43/47/474011
Ferromagnetic nanoparticles for magnetic hyperthermia and thermoablation therapy
E. Kita (2010)
10.1002/JBM.A.31724
Magnetic nanoparticles for improving cell invasion in tissue engineering.
Takuro Sasaki (2008)
10.1016/j.nano.2010.02.002
In vivo evaluation of the biodistribution and safety of PLGA nanoparticles as drug delivery systems.
B. Semete (2010)
10.1111/j.1750-3841.2009.01457.x
Bioavailability and delivery of nutraceuticals using nanotechnology.
Q. Huang (2010)
10.1021/ja309812z
Nanoparticle adhesion to the cell membrane and its effect on nanoparticle uptake efficiency.
A. Leśniak (2013)
10.1038/nbt1201-1141
Magnetodendrimers allow endosomal magnetic labeling and in vivo tracking of stem cells
J. Bulte (2001)
10.1016/B978-0-12-407722-5.00001-3
Cancer Theranostics: An Introduction
Xiaoyuan Chen (2014)
10.1088/1468-6996/16/2/023501
Recent progress on magnetic iron oxide nanoparticles: synthesis, surface functional strategies and biomedical applications
Wei Wu (2015)
10.1007/s11947-010-0328-2
Nanotechnology for the Food and Bioprocessing Industries
S. Neethirajan (2011)
10.1016/J.JMMM.2013.11.006
Heating efficiency in magnetic nanoparticle hyperthermia
Alison E Deatsch (2014)
10.1007/s13346-015-0218-2
Multifunctional nanoparticles for use in theranostic applications
James T. Cole (2015)
10.1016/J.JMMM.2008.11.013
Synthesis of magnetite nanoparticles via a solvent-free thermal decomposition route
D. Maity (2009)
10.1016/j.addr.2009.03.010
Effects of nanomaterial physicochemical properties on in vivo toxicity.
Kristin L Aillon (2009)



This paper is referenced by
Semantic Scholar Logo Some data provided by SemanticScholar